|
Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina |
Elgart JF, Caporale JE, Gonzalez L, Aiello E, Waschbusch M, Gagliardino JJ |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Elgart JF, Caporale JE, Gonzalez L, Aiello E, Waschbusch M, Gagliardino JJ. Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina. Health Economics Review 2013; 3(1):11 Indexing Status Subject indexing assigned by CRD MeSH Adamantane; Argentina; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Metformin; Quality-Adjusted Life Years AccessionNumber 22013021038 Date bibliographic record published 06/06/2013 |
|
|
|